Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Identification and characterization of novel Faecalibacterium prausnitzii strains from infant gut microbiota with potential pharmabiotic applications

Faecalibacterium prausnitzii is a dominant commensal bacterium in the human gut, widely known for its production of bioactive metabolites and currently considered a potential pharmabiotic for the treatment of various human diseases. In this study, ten novel strains of Faecalibacterium prausnitzii were isolated fro...

O. Galanova, Mikhail D. Akulinin, D. Troshina et al. · 0 citations
Review Open access 2026

The Use of microRNAs for the Treatment of Atherosclerosis: Current Status

: Atherosclerosis remains the principal substrate of ischaemic heart disease and stroke, and residual cardiovascular risk persists despite intensive lipid-lowering and anti-inflammatory therapy. microRNAs (miRNAs) act as integrative regulators of endothelial activation, macrophage polarisation, foam cell formation, smo...

A. Blagov, A. Vatlin, D. Borodko et al. · 0 citations
Review Open access Oct 2026

SIGNALING PATHWAYS: A KEY TO UNLOCKING NEW TREATMENTS FOR SJÖGREN'S SYNDROME

This paper advocates for a multi-target therapeutic approach in SS, aiming to mitigate the intricate cytokine network and restore glandular function, ultimately improving patient outcomes.

A. V. Poznyak, A. Vatlin, D. Borodko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.